ZeroTo510

ZeroTo510 is a highly specialized medical device accelerator based in Memphis, Tennessee, renowned for its unique focus on guiding early-stage companies through the complex regulatory landscape of the U.S. Food and Drug Administration (FDA), particularly the 510(k) clearance process. Launched to capitalize on Memphis's strong biomedical ecosystem, the program aims to accelerate the commercialization of innovative medical technologies. It provides a structured environment for entrepreneurs to de-risk their ventures and prepare for market entry.

The accelerator runs a rigorous 12-week program, offering participating startups a comprehensive suite of resources including mentorship from industry experts, access to a network of clinicians and investors, and hands-on guidance for product development and regulatory strategy. A cornerstone of their support is a significant initial investment. Each accepted company typically receives a $100,000 capital infusion, structured as a convertible note or equity, designed to help them achieve critical milestones during the program and beyond. This consistent investment amount underscores their commitment to providing tangible financial support alongside strategic guidance.

ZeroTo510 has established itself as a pivotal player in the medical device startup ecosystem. Since its inception, the accelerator has graduated over 60 companies, a testament to its consistent pipeline of promising ventures. These alumni companies have collectively demonstrated remarkable success in attracting further capital, raising over $150 million in follow-on funding from various investors. This impressive track record highlights ZeroTo510's effectiveness in preparing companies for subsequent funding rounds and ultimately bringing innovative medical devices to market, contributing significantly to both healthcare advancements and economic development in the region.